The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression

被引:27
|
作者
Barnett, Paul G. [1 ,2 ]
Wong, Wynnie [1 ]
Hall, Sharon [1 ]
机构
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA
[2] Stanford Univ, Stanford, CA 94305 USA
关键词
cost-effectiveness; cost; depression; smoking cessation;
D O I
10.1111/j.1360-0443.2008.02167.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims Smoking cessation programs are highly cost-effective. The cost-effectiveness of programs for psychiatric patients may be affected by differences in cost, efficacy, survival and quality of life. We evaluated cost-effectiveness of a program for smokers being treated for depression. Design A randomized trial compared brief contact to a stepped smoking cessation program in 322 cigarette smoking mental health out-patients. We determined the intervention's direct cost. Because smoking cessation may affect short-term use of mental health care, we used administrative databases and self-report to find mental health-care cost. Findings The 163 individuals randomized to stepped care received an average of $346 of smoking cessation services, including $221 for computer-mediated assessments of readiness to quit, and $124 for counseling, nicotine replacement therapy and bupropion. The cessation program was used by 53 participants. Total cost of smoking cessation and mental health services was $4805 in the stepped care group and $4173 in the brief-contact care group (not significantly different). After 18 months of follow-up, the stepped care group had 5.5% greater abstinence from smoking. Smoking cessation services cost $6204 per successful quit. Cessation services and mental health care cost was $11 496 per successful quit. Conclusion If smoking cessation yields 1.2 years additional life, the cessation services cost $5170 per life-year, and cessation services and mental health care cost $9580 per life-year. Even if quitting does not increase survival of depressed individuals as well as in other smokers, the stepped care intervention is likely to be regarded as cost-effective.
引用
收藏
页码:834 / 840
页数:7
相关论文
共 50 条
  • [21] Cost-Effectiveness of a Comprehensive Primary Care Smoking Treatment Program
    Mundt, Marlon P.
    Mccarthy, Danielle E.
    Baker, Timothy B.
    Zehner, Mark E.
    Zwaga, Deejay
    Fiore, Michael C.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2024, 66 (03) : 435 - 443
  • [22] Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
    Hoogendoorn, Martine
    Feenstra, Talitha L.
    Hoogenveen, Rudolf T.
    Rutten-van Molken, Maureen P. M. H.
    THORAX, 2010, 65 (08) : 711 - 718
  • [23] LONG-TERM EFFECTIVENESS AND COST-EFFECTIVENESS OF SMOKING CESSATION INTERVENTIONS IN PATIENTS WITH COPD
    Hoogendoorn, M.
    Feenstra, T.
    Hoogenveen, R. T.
    Rutten-van Moelken, M. P.
    VALUE IN HEALTH, 2010, 13 (07) : A322 - A323
  • [24] COST-EFFECTIVENESS ANALYSIS OF SMOKING CESSATION INTERVENTIONS IN MALAYSIA
    Neoh, C. F.
    Ibrahim, N. H.
    Ismail, H.
    Hong, Y. H.
    VALUE IN HEALTH, 2018, 21 : S234 - S235
  • [25] Cost-effectiveness of universally funding smoking cessation pharmacotherapy
    Altman, Daniel
    Clement, Fiona M.
    Barnieh, Lianne
    Manns, Braden
    Penz, Erika
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2019, 3 (02) : 67 - 75
  • [26] Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students
    Jonah Popp
    John A. Nyman
    Xianghua Luo
    Jill Bengtson
    Katherine Lust
    Lawrence An
    Jasjit S. Ahluwalia
    Janet L. Thomas
    The European Journal of Health Economics, 2018, 19 : 1319 - 1333
  • [27] The cost-effectiveness of the nicotine transdermal patch for smoking cessation
    Wasley, MA
    McNagny, SE
    Phillips, VL
    Ahluwalia, JS
    PREVENTIVE MEDICINE, 1997, 26 (02) : 264 - 270
  • [28] THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND
    Walczak, J.
    Nogas, G.
    Dybek-Karpiuk, A.
    Augustynska, J.
    Stelmachowski, J.
    Garbacka, M.
    Obrzut, G.
    Pawlik, D.
    VALUE IN HEALTH, 2009, 12 (07) : A303 - A303
  • [29] Cost-Effectiveness of Universally Funding Smoking Cessation Pharmacotherapy
    Altman, Daniel
    Clement, Fiona
    Barnieh, Lianne
    Manns, Braden
    Penz, Erika
    CHEST, 2016, 150 (04) : 1303A - 1303A
  • [30] COST-EFFECTIVENESS OF FINANCIAL INCENTIVES FOR SMOKING CESSATION IN PREGNANCY
    Boyd, Kathleen A.
    Tappin, David M.
    Bauld, Linda
    ADDICTION, 2016, 111 (06) : 1115 - 1117